Monday, December 21, 2020 9:32:18 AM
Patents and patent application provide additional coverage for company’s therapeutic for patients with advanced solid tumors
December 21, 2020 09:15 AM Eastern Standard Time
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, today announced that the U.S. Patent and Trademark Office has issued two new patents, No.10,792,251 (the ‘251 patent) and No. 10,837,018 (the ‘018 patent), and allowed U.S. patent application 14/907,430 (the ‘430 application), further strengthening the Company’s intellectual property position and coverage for the Company’s therapeutic product candidate, cavrotolimod.
The ‘018 patent and the ‘430 application, both titled, “Spherical Nucleic Acid-based Constructs as Immunostimulatory Agents for Prophylactic and Therapeutic Use,” covers nanoparticles with a corona of CpG oligonucleotides and their methods for treating cancer.
The ‘251 patent, jointly owned by the Company and Northwestern University, titled, “Liposomal Particles, Methods of Making Same and Uses Thereof,” is directed to liposomal nanoparticles with toll-like receptor 9 (TLR9) agonist oligonucleotides and methods for treating cancer.
“The two issued patents and the soon-to-be-issued patent demonstrate our commitment to developing cavrotolimod, which is currently in a Phase 2 clinical trial for the potential treatment of Merkel cell carcinoma and cutaneous squamous cell carcinoma,” said David Giljohann, Chief Executive Officer of Exicure. “We are pleased with cavrotolimod’s development to date and excited about its potential to address unmet need for patients living with these rare forms of skin cancers.”
https://www.businesswire.com/news/home/20201221005412/en/Exicure-Announces-Issuance-of-Two-New-U.S.-Patents-and-A-New-Patent-Allowance-Covering-Cavrotolimod-Through-2034
MegaDeath, changed due to circumstances of COVID-19 pandemic.
Recent XCUR News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/24/2024 01:48:14 AM
- CORRECTING and REPLACING Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes • Business Wire • 12/21/2024 06:48:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2024 10:28:55 PM
- Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes • Business Wire • 12/20/2024 09:42:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 09:08:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2024 10:17:01 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/02/2024 05:00:52 PM
- Form SC 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 11/29/2024 10:51:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/26/2024 09:36:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2024 09:27:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/22/2024 09:30:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2024 09:25:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:38:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:18:15 PM
- Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial Results • Business Wire • 11/14/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 08:42:50 PM
- AIG names new CFO; Progyny Drops 24% After Losing Key 2025 Contract; Exicure Jumps 190% With Nasdaq Extension • IH Market News • 09/19/2024 10:26:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 08:18:06 PM
- Exicure, Inc. Receives Extension from Nasdaq Hearings Panel • Business Wire • 09/18/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 01:41:12 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/17/2024 01:38:56 AM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM
UAV Corp. (UMAV) Reduces Authorized Shares by 1.2 Billion, Demonstrating Commitment to Shareholders; New Authorized Share Count Approved at 800 Million • UMAV • Dec 17, 2024 12:00 PM